BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
BOCA RATON, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
New VCIEL scale provides a more sensitive and quantitative metric of small intestinal health for monitoring Celiac Disease severity and treatment efficacy Special editorial highlights the...
BOCA RATON, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (Nasdaq: ENTO) (“Entero” or the “Company”), a late clinical-stage...
BOCA RATON, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0044 | -1.32930513595 | 0.331 | 0.359 | 0.32 | 36114 | 0.33498647 | CS |
4 | -0.0834 | -20.3414634146 | 0.41 | 0.46 | 0.28 | 121730 | 0.37890469 | CS |
12 | -0.7334 | -69.1886792453 | 1.06 | 1.15 | 0.185 | 592291 | 0.32322814 | CS |
26 | -2.6334 | -88.9662162162 | 2.96 | 3.16 | 0.185 | 402708 | 0.4169703 | CS |
52 | -2.6334 | -88.9662162162 | 2.96 | 3.16 | 0.185 | 402708 | 0.4169703 | CS |
156 | -2.6334 | -88.9662162162 | 2.96 | 3.16 | 0.185 | 402708 | 0.4169703 | CS |
260 | -2.6334 | -88.9662162162 | 2.96 | 3.16 | 0.185 | 402708 | 0.4169703 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관